Dr. Len Calabrese and Dr. Cassandra Calabrese Discuss Herpes Zoster Vaccination in At-risk Populations: Patient Education and Management of Side Effects

Author(s)/Faculty: Cassandra Calabrese, DO; Leonard H. Calabrese, DO
Release Date: 10/31/2020Expiration Date: 10/30/2021
Credit Type: CMENumber of Credits: 0.25
Content Type: PodcastProvider:
Shingles, also called herpes zoster (HZ), is a painful rash that develops due to reactivation of the varicella zoster virus, which causes chicken pox. Approximately 1 in 3 individuals in the United States will develop shingles during their lifetime, with adults over 50 years of age and immunocompromised individuals being at highest risk. Recent developments in HZ prevention include a new recombinant zoster vaccine, which is now recommended as the preferred shingles vaccine in updated guidelines from the Advisory Committee on Immunization Practices (ACIP). Effective prevention and risk management strategies are particularly important for patients with immune-mediated diseases. In this CME podcast, experts will review vaccine side effects and provide guidance on effective patient education strategies to enhance vaccine uptake.